S K Fridkin

Summary

Affiliation: Centers for Disease Control and Prevention
Country: USA

Publications

  1. ncbi request reprint Epidemiological and microbiological characterization of infections caused by Staphylococcus aureus with reduced susceptibility to vancomycin, United States, 1997-2001
    Scott K Fridkin
    Division of Healthcare Quality Promotion, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Clin Infect Dis 36:429-39. 2003
  2. ncbi request reprint Methicillin-resistant Staphylococcus aureus disease in three communities
    Scott K Fridkin
    Division of Bacterial and Mycotic Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    N Engl J Med 352:1436-44. 2005
  3. ncbi request reprint Routine cycling of antimicrobial agents as an infection-control measure
    Scott K Fridkin
    Division of Healthcare Quality Promotion, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, 30333, USA
    Clin Infect Dis 36:1438-44. 2003
  4. ncbi request reprint The changing face of fungal infections in health care settings
    Scott K Fridkin
    Mycotic Diseases Branch, Division of Bacterial and Mycotic Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    Clin Infect Dis 41:1455-60. 2005
  5. pmc Monitoring antimicrobial use and resistance: comparison with a national benchmark on reducing vancomycin use and vancomycin-resistant enterococci
    Scott K Fridkin
    Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    Emerg Infect Dis 8:702-7. 2002
  6. pmc Temporal changes in prevalence of antimicrobial resistance in 23 US hospitals
    Scott K Fridkin
    Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    Emerg Infect Dis 8:697-701. 2002
  7. ncbi request reprint The effect of vancomycin and third-generation cephalosporins on prevalence of vancomycin-resistant enterococci in 126 U.S. adult intensive care units
    S K Fridkin
    Division of Healthcare Quality Promotion, National Center for Infectious Diseases, Centers for Disease Control and Prevention, MS A 35, 1600 Clifton Road, Atlanta, GA 30333, USA
    Ann Intern Med 135:175-83. 2001
  8. ncbi request reprint Antimicrobial resistance prevalence rates in hospital antibiograms reflect prevalence rates among pathogens associated with hospital-acquired infections
    S K Fridkin
    Hospital Infections Program, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Clin Infect Dis 33:324-30. 2001
  9. ncbi request reprint Surveillance of antimicrobial use and antimicrobial resistance in United States hospitals: project ICARE phase 2. Project Intensive Care Antimicrobial Resistance Epidemiology (ICARE) hospitals
    S K Fridkin
    Hospital Infections Program, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    Clin Infect Dis 29:245-52. 1999
  10. ncbi request reprint Antimicrobial resistance in intensive care units
    S K Fridkin
    Hospital Infections Program, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
    Clin Chest Med 20:303-16, viii. 1999

Detail Information

Publications57

  1. ncbi request reprint Epidemiological and microbiological characterization of infections caused by Staphylococcus aureus with reduced susceptibility to vancomycin, United States, 1997-2001
    Scott K Fridkin
    Division of Healthcare Quality Promotion, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Clin Infect Dis 36:429-39. 2003
    ..Independent risk factors for being a case patient included antecedent vancomycin use and prior oxacillin-resistant S. aureus infection 2 or 3 months before the current infection...
  2. ncbi request reprint Methicillin-resistant Staphylococcus aureus disease in three communities
    Scott K Fridkin
    Division of Bacterial and Mycotic Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    N Engl J Med 352:1436-44. 2005
    ..Methicillin-resistant Staphylococcus aureus (MRSA) infection has emerged in patients who do not have the established risk factors. The national burden and clinical effect of this novel presentation of MRSA disease are unclear...
  3. ncbi request reprint Routine cycling of antimicrobial agents as an infection-control measure
    Scott K Fridkin
    Division of Healthcare Quality Promotion, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, 30333, USA
    Clin Infect Dis 36:1438-44. 2003
    ..However, optimizing antimicrobial use through traditional and novel methods (e.g., computer decision support) should not be abandoned...
  4. ncbi request reprint The changing face of fungal infections in health care settings
    Scott K Fridkin
    Mycotic Diseases Branch, Division of Bacterial and Mycotic Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    Clin Infect Dis 41:1455-60. 2005
    ..In this context, the changing pathogen profiles, unique antifungal susceptibilities, and approaches to treatment are outlined...
  5. pmc Monitoring antimicrobial use and resistance: comparison with a national benchmark on reducing vancomycin use and vancomycin-resistant enterococci
    Scott K Fridkin
    Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    Emerg Infect Dis 8:702-7. 2002
    ..5% compared with mean increase of 5.7%, p<0.001). In this study, practice changes focused towards specific ICUs were associated with decreases in ICU vancomycin use and VRE prevalence...
  6. pmc Temporal changes in prevalence of antimicrobial resistance in 23 US hospitals
    Scott K Fridkin
    Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    Emerg Infect Dis 8:697-701. 2002
    ..The increases seen are of concern; differences in factors present outside ICUs, such as excessive quinolone use or inadequate infection-control practices, may explain the observed trends...
  7. ncbi request reprint The effect of vancomycin and third-generation cephalosporins on prevalence of vancomycin-resistant enterococci in 126 U.S. adult intensive care units
    S K Fridkin
    Division of Healthcare Quality Promotion, National Center for Infectious Diseases, Centers for Disease Control and Prevention, MS A 35, 1600 Clifton Road, Atlanta, GA 30333, USA
    Ann Intern Med 135:175-83. 2001
    ..Identifying modifiable institutional factors can advance quality-improvement efforts to minimize hospital-acquired infections with VRE...
  8. ncbi request reprint Antimicrobial resistance prevalence rates in hospital antibiograms reflect prevalence rates among pathogens associated with hospital-acquired infections
    S K Fridkin
    Hospital Infections Program, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Clin Infect Dis 33:324-30. 2001
    ..Hospital antibiograms may underestimate the relative frequency of methicillin resistance among Staphylococcus species when associated with hospital-acquired infections...
  9. ncbi request reprint Surveillance of antimicrobial use and antimicrobial resistance in United States hospitals: project ICARE phase 2. Project Intensive Care Antimicrobial Resistance Epidemiology (ICARE) hospitals
    S K Fridkin
    Hospital Infections Program, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    Clin Infect Dis 29:245-52. 1999
    ..These comparative data on use and resistance among similar areas (i.e., ICU or other inpatient areas) can be used as a benchmark by participating hospitals to focus their efforts at addressing antimicrobial resistance...
  10. ncbi request reprint Antimicrobial resistance in intensive care units
    S K Fridkin
    Hospital Infections Program, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
    Clin Chest Med 20:303-16, viii. 1999
    ..e., patient isolation, hand washing, glove use, and appropriate gown use), and implementation of a systematic review of antimicrobial use...
  11. ncbi request reprint Vancomycin-intermediate and -resistant Staphylococcus aureus: what the infectious disease specialist needs to know
    S K Fridkin
    Hospital Infections Program, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA
    Clin Infect Dis 32:108-15. 2001
    ..aureus are likely to be encountered...
  12. ncbi request reprint Determinants of vancomycin use in adult intensive care units in 41 United States hospitals
    S K Fridkin
    Hospital Infections Program, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    Clin Infect Dis 28:1119-25. 1999
    ..Efforts to reduce these rates through infection control activities should be included in hospitals' efforts to reduce vancomycin use...
  13. ncbi request reprint Ability of laboratories to detect emerging antimicrobial resistance in nosocomial pathogens: a survey of project ICARE laboratories
    C D Steward
    Hospital Infections Program, Centers for Disease Control and Prevention, 1600 Clifton Rd, NE G08 Atlanta, GA 30333, USA
    Diagn Microbiol Infect Dis 38:59-67. 2000
    ..This highlights the need for monitoring how well susceptibility test systems in clinical laboratories detect emerging resistance...
  14. ncbi request reprint Outbreak of bloodstream infection with the mold Phialemonium among patients receiving dialysis at a hemodialysis unit
    Thomas Clark
    Epidemic Intelligence Service, Office of Workforce and Career Development, Atlanta, GA, USA
    Infect Control Hosp Epidemiol 27:1164-70. 2006
    ..Molds are a rare cause of disseminated infection among dialysis patients...
  15. ncbi request reprint Determining risk factors for candidemia among newborn infants from population-based surveillance: Baltimore, Maryland, 1998-2000
    Sharmila S Shetty
    Mycotic Diseases Branch, Division of Bacterial and Mycotic Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA
    Pediatr Infect Dis J 24:601-4. 2005
    ..Our objective was to determine risks factors for late onset candidemia, independent of birth weight, in newborn infants...
  16. pmc Vancomycin-intermediate Staphylococcus aureus in a home health-care patient
    J C Hageman
    Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    Emerg Infect Dis 7:1023-5. 2001
    ..The patient was treated successfully with antimicrobial therapy, biliary drainage, and reconstruction. Standard precautions in the home health setting appear successful in preventing transmission...
  17. doi request reprint NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007
    Alicia I Hidron
    Department of Medicine, Division of Infectious Diseases, Emory University School of Medicine, Atlanta, Georgia, USA
    Infect Control Hosp Epidemiol 29:996-1011. 2008
    ....
  18. doi request reprint Nosocomial acquisition of Pseudomonas aeruginosa resistant to both ciprofloxacin and imipenem: a risk factor and laboratory analysis
    M R Mueller
    Rollins School of Public Health, Emory University, Atlanta, GA, USA
    Eur J Clin Microbiol Infect Dis 27:565-70. 2008
    ..Fluoroquinolone use was not a risk factor for acquisitions of dually resistant P. aeruginosa. The absence of OprN in these isolates suggests that dual resistance is not due to mexT mutations...
  19. ncbi request reprint Increasing prevalence of antimicrobial resistance in intensive care units
    S K Fridkin
    Hospital Infections Program, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA
    Crit Care Med 29:N64-8. 2001
    ..Crit Care Med 2001; 29[Suppl.]: N64-N68)..
  20. ncbi request reprint Secular trend of hospital-acquired candidemia among intensive care unit patients in the United States during 1989-1999
    W E Trick
    Health Outcomes Branch, Centers for Disease Control and Prevention, Public Health Service, US Department of Health and Human Services, Atlanta, GA 30333, USA
    Clin Infect Dis 35:627-30. 2002
    ..During the study period, there was a significant decrease in the incidence of C. albicans BSI (P<.001) and a significant increase in the incidence of Candida glabrata BSI (P=.05)...
  21. pmc Bioterrorism-related inhalational anthrax: the first 10 cases reported in the United States
    J A Jernigan
    NCID, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    Emerg Infect Dis 7:933-44. 2001
    ..With multidrug antibiotic regimens and supportive care, survival of patients (60%) was markedly higher (<15%) than previously reported...
  22. ncbi request reprint Multistate outbreak of Fusarium keratitis associated with use of a contact lens solution
    Douglas C Chang
    Mycotic Diseases Branch, Career Development Division, Office of Workforce and Career Development, Centers for Disease Control and Prevention, Atlanta, GA, USA
    JAMA 296:953-63. 2006
    ..Beginning in March 2006, the Centers for Disease Control and Prevention received multiple reports of Fusarium keratitis among contact lens wearers...
  23. pmc Evaluation of amphotericin B interpretive breakpoints for Candida bloodstream isolates by correlation with therapeutic outcome
    Benjamin J Park
    Mycotic Diseases Branch, Division of Bacterial and Mycotic Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, 1600 Clifton Rd, N E, Mailstop C 09, Atlanta, GA 30333, USA
    Antimicrob Agents Chemother 50:1287-92. 2006
    ..06 to 2 microg/ml, respectively). Etest produced the widest distribution of MICs (0.094 to 2 microg/ml). However, none of the test formats studied generated results that significantly correlated with therapeutic success or failure...
  24. ncbi request reprint Prevalence of Staphylococcus aureus nasal colonization in the United States, 2001-2002
    Matthew J Kuehnert
    National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    J Infect Dis 193:172-9. 2006
    ..Although methicillin-resistant S. aureus (MRSA) infection has become increasingly reported, population-based S. aureus and MRSA colonization estimates are lacking...
  25. ncbi request reprint Implications of detecting the mold Syncephalastrum in clinical specimens of New Orleans residents after Hurricanes Katrina and Rita
    Carol Y Rao
    Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    J Occup Environ Med 49:411-6. 2007
    ..Only one patient reported significant exposure to mold (working on mold remediation without wearing a respirator) on the day of his incident culture...
  26. ncbi request reprint Invasive methicillin-resistant Staphylococcus aureus infections in the United States
    R Monina Klevens
    Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
    JAMA 298:1763-71. 2007
    ..As the epidemiology of infections with methicillin-resistant Staphylococcus aureus (MRSA) changes, accurate information on the scope and magnitude of MRSA infections in the US population is needed...
  27. doi request reprint Recommendations for metrics for multidrug-resistant organisms in healthcare settings: SHEA/HICPAC Position paper
    Adam L Cohen
    Divisions of Bacterial Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    Infect Control Hosp Epidemiol 29:901-13. 2008
  28. pmc Community-associated methicillin-resistant Staphylococcus aureus and healthcare risk factors
    R Monina Klevens
    Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    Emerg Infect Dis 12:1991-3. 2006
    ..Of patients with HRFs, 18%-28% had a "community-associated" strain, primarily USA300; of patients without HRFs, 26% had a "healthcare-associated" strain, typically USA100...
  29. doi request reprint Methicillin-resistant Staphylococcus aureus central line-associated bloodstream infections in US intensive care units, 1997-2007
    Deron C Burton
    Surveillance Branch, Division of Healthcare Quality Promotion, National Center for Preparedness, Detection, and Control of Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    JAMA 301:727-36. 2009
    ..Concerns about rates of methicillin-resistant Staphylococcus aureus (MRSA) health care-associated infections have prompted calls for mandatory screening or reporting in efforts to reduce MRSA infections...
  30. pmc Characterization of methicillin-resistant Staphylococcus aureus isolates collected in 2005 and 2006 from patients with invasive disease: a population-based analysis
    Brandi Limbago
    Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
    J Clin Microbiol 47:1344-51. 2009
    ..6%), in addition to beta-lactam agents. This collection provides a reference collection of MRSA isolates associated with invasive disease, collected in 2005 and 2006 in the United States, for future comparison and ongoing studies...
  31. doi request reprint Contaminated product water as the source of Phialemonium curvatum bloodstream infection among patients undergoing hemodialysis
    Carol Y Rao
    Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    Infect Control Hosp Epidemiol 30:840-7. 2009
    ..We investigated a cluster of cases of bloodstream infection (BSI) due to the mold Phialemonium at a hemodialysis center in Illinois and conducted a cohort study to identify risk factors...
  32. doi request reprint Health care-associated invasive MRSA infections, 2005-2008
    Alexander J Kallen
    Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
    JAMA 304:641-8. 2010
    ..Whether there have been changes in MRSA infection incidence as these programs become established is unknown; however, recent data have shown that rates of MRSA bloodstream infections (BSIs) in intensive care units are decreasing...
  33. doi request reprint Trends in incidence of late-onset methicillin-resistant Staphylococcus aureus infection in neonatal intensive care units: data from the National Nosocomial Infections Surveillance System, 1995-2004
    Fernanda C Lessa
    Division of Healthcare Quality Promotion, National Center for Preparedness, Detection, and Control of Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA
    Pediatr Infect Dis J 28:577-81. 2009
    ..We assessed the scope and magnitude of MRSA infections with disease onset after 3 days of age (late-onset MRSA infections) in NICUs...
  34. pmc Epidemiologic and molecular characterization of an outbreak of Candida parapsilosis bloodstream infections in a community hospital
    Thomas A Clark
    Epidemic Intelligence Service, Epidemiology Program Office, Division of Applied Public Health Training, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    J Clin Microbiol 42:4468-72. 2004
    ..parapsilosis bloodstream infections in adults resulted from an interplay of host, environment, and pathogen factors. Recommendations for control measures focused on improving hand hygiene compliance...
  35. pmc Drug-resistant Streptococcus pneumoniae and methicillin-resistant Staphylococcus aureus surveillance
    Leigh Ann Hawley
    Division of Bacterial and Mycotic Diseases, Centers for Disease Control and Prevention, 1600 Clifton Road, Mailstop C23, Atlanta, GA 30333, USA
    Emerg Infect Dis 9:1358-9. 2003
  36. pmc Evaluation of the NCCLS extended-spectrum beta-lactamase confirmation methods for Escherichia coli with isolates collected during Project ICARE
    Fred C Tenover
    Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    J Clin Microbiol 41:3142-6. 2003
    ..NCCLS has incorporated this change in the cefpodoxime screening breakpoint in its recent documents...
  37. ncbi request reprint Changing incidence of Candida bloodstream infections among NICU patients in the United States: 1995-2004
    Scott K Fridkin
    Division of Bacterial and Mycotic Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, US Department of Health and Human Services, Atlanta, Georgia 30333, USA
    Pediatrics 117:1680-7. 2006
    ..We evaluated the annual incidence of neonatal candidemia and the frequency of disease caused by different species of Candida among neonates in the United States...
  38. ncbi request reprint No evidence of a mild form of inhalational Bacillus anthracis infection during a bioterrorism-related inhalational anthrax outbreak in Washington, D.C., in 2001
    Henry C Baggett
    Arctic Investigations Program, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Anchorage, AK, USA
    Clin Infect Dis 41:991-7. 2005
    ..anthracis infection. We hypothesized that early antibiotic use could have decreased the sensitivity of diagnostic tests or that bioterrorism-related inhalational anthrax may include mild disease...
  39. ncbi request reprint Infection with vancomycin-resistant Staphylococcus aureus containing the vanA resistance gene
    Soju Chang
    Epidemic Intelligence Service, Division of Applied Public Health Training, Epidemiology Program Office, Centers for Disease Control and Prevention, Atlanta 30333, USA
    N Engl J Med 348:1342-7. 2003
  40. ncbi request reprint Outbreak of cutaneous Rhizopus arrhizus infection associated with karaya ostomy bags
    Mysheika LeMaile-Williams
    Epidemic Intelligence Service, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, 30333 USA
    Clin Infect Dis 43:e83-8. 2006
    ..We investigated an outbreak involving 2 patients hospitalized at hospital A with cutaneous Rhizopus arrhizus (oryzae) infections of surgically created stomas...
  41. doi request reprint Evaluating the potential public health impact of a Staphylococcus aureus vaccine through use of population-based surveillance for invasive methicillin-resistant S. aureus disease in the United States
    Cynthia A Lucero
    Centers for Disease Control and Prevention, NE, Atlanta, GA 30333, United States
    Vaccine 27:5061-8. 2009
    ..aureus vaccine could result in substantial reductions in invasive MRSA disease incidence. As candidate vaccines are evaluated, these data will be important in determining the optimal vaccination strategy...
  42. ncbi request reprint Incidence of invasive aspergillosis following hematopoietic stem cell and solid organ transplantation: interim results of a prospective multicenter surveillance program
    J Morgan
    Mycotic Diseases Branch, Centers for Disease Control and Prevention, 1600 Clifton Road NE, Atlanta, GA 30333, USA
    Med Mycol 43:S49-58. 2005
    ..Our CI figures are lower compared to those of previous reports. The reasons for this are unclear, but may be related to changes in transplantation practices, diagnostic methods, and supportive care...
  43. ncbi request reprint Status of tuberculosis infection control programs at United States hospitals, 1989 to 1992. APIC. Association for Professionals in Infection Control and Epidemiology
    R L Sinkowitz
    Hospital Infections Program, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Am J Infect Control 24:226-34. 1996
    ....
  44. ncbi request reprint Antimicrobial proficiency testing of National Nosocomial Infections Surveillance System hospital laboratories
    Jeffrey C Hageman
    Division of Healthcare Quality Promotion, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    Infect Control Hosp Epidemiol 24:356-61. 2003
    ..To validate select antimicrobial susceptibility testing results and to identify test methods that tend to produce errors, we conducted proficiency testing among NNIS System hospital laboratories...
  45. doi request reprint Outcomes among inmates treated for coccidioidomycosis at a correctional institution during a community outbreak, Kern County, California, 2004
    Lauren A Burwell
    Epidemic Intelligence Service, Office of Workforce and Career Development, and Mycotic Diseases Branch, Division of Foodborne, Bacterial, and Mycotic Diseases, National Center for Zoonotic, Vector Borne, and Enteric Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    Clin Infect Dis 49:e113-9. 2009
    ..In response to an increase of coccidioidomycosis at a correctional institution in an endemic area, physicians initiated an enhanced diagnosis and treatment program...
  46. ncbi request reprint Antifungal prophylaxis to prevent neonatal candidiasis: a survey of perinatal physician practices
    Lauren A Burwell
    Office of Workforce and Career Development, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
    Pediatrics 118:e1019-26. 2006
    ..The extent of antifungal prophylaxis use to prevent neonatal candidemia is unknown...
  47. ncbi request reprint Emergence of community-associated methicillin-resistant Staphylococcus aureus at a Memphis, Tennessee Children's Hospital
    Steven C Buckingham
    Department of Pediatrics, University of Tennessee Health Science Center, Memphis, TN, USA
    Pediatr Infect Dis J 23:619-24. 2004
    ..An epidemiologic investigation was performed because of a perceived increase in infections caused by community-associated methicillin-resistant Staphylococcus aureus (MRSA) among children in the greater Memphis area...
  48. ncbi request reprint The epidemiology of vancomycin-resistant Enterococcus colonization in a medical intensive care unit
    David K Warren
    Division of Infectious Diseases, Washington University School of Medicine, St Louis, Missouri 63110, USA
    Infect Control Hosp Epidemiol 24:257-63. 2003
    ..To determine the epidemiology of colonization with vancomycin-resistant Enterococcus (VRE) among intensive care unit (ICU) patients...
  49. ncbi request reprint More challenges in the prevention and management of community-associated, methicillin-resistant Staphylococcus aureus skin disease
    Rachel Gorwitz
    Ann Intern Med 148:310-2. 2008
  50. ncbi request reprint Cycling empirical antimicrobial agents to prevent emergence of antimicrobial-resistant Gram-negative bacteria among intensive care unit patients
    David K Warren
    Department of Medicine, Washington University School of Medicine, St Louis, MO 63110, USA
    Crit Care Med 32:2450-6. 2004
    ..To determine the impact of the rotation of antimicrobial agents on the rates of infection, intestinal colonization, and acquisition with antimicrobial-resistant Gram-negative bacteria...
  51. ncbi request reprint Excess costs of hospital care associated with neonatal candidemia
    P Brian Smith
    Department of Pediatrics, 3179 Duke University Medical Center, Durham NC, 27710, USA
    Pediatr Infect Dis J 26:197-200. 2007
    ..Candida is an increasingly important nosocomial pathogen within intensive care nurseries. The purpose of this study was to determine the attributable cost of candidemia in neonates...
  52. ncbi request reprint Management of inpatients colonized or infected with antimicrobial-resistant bacteria in hospitals in the United States
    Rebecca H Sunenshine
    Division of Infectious Diseases, Department of Medicine, Oregon Health and Science University, Portland, Oregon, USA
    Infect Control Hosp Epidemiol 26:138-43. 2005
    ..S. hospitals implement these measures on a routine basis and whether infectious diseases consultants endorse their use...
  53. pmc Epidemiology and predictors of mortality in cases of Candida bloodstream infection: results from population-based surveillance, barcelona, Spain, from 2002 to 2003
    Benito Almirante
    Infectious Diseases Division, Hospital Universitari Vall d Hebron, Avda Vall d Hebron, 119 129, 08035 Barcelona, Spain
    J Clin Microbiol 43:1829-35. 2005
    ..Antifungal medication and catheter removal are critical in preventing mortality...
  54. ncbi request reprint The impact of an antibiotic cycling program on empirical therapy for gram-negative infections
    Liana R Merz
    Division of Infectious Diseases, Washington University School of Medicine, Box 8051, 660 S Euclid Ave, Saint Louis, MO 63110, USA
    Chest 130:1672-8. 2006
    ..Therapy cycling empiric antibiotics between various classes may influence bacterial resistance patterns. Understanding the impact of cycling on the appropriate treatment of suspected Gram-negative infections is important...
  55. ncbi request reprint Epidemiology of community-onset candidemia in Connecticut and Maryland
    Andre N Sofair
    Yale University School of Medicine, New Haven, Connecticut, USA
    Clin Infect Dis 43:32-9. 2006
    ..e., community-onset candidemia). We compared the characteristics of patients who developed candidemia by the timing of onset of infection...
  56. ncbi request reprint Vancomycin-resistant Staphylococcus aureus in the absence of vancomycin exposure
    Cynthia J Whitener
    The Penn State Milton S Hershey Medical Center, Hershey, Pennsylvania 17033, USA
    Clin Infect Dis 38:1049-55. 2004
    ..For clinical and public health reasons, it is essential that microbiology laboratories adequately test for vancomycin-resistance in S. aureus...
  57. ncbi request reprint Candidemia is costly--plain and simple
    Scott K Fridkin
    Clin Infect Dis 41:1240-1. 2005